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MAGNETIC RESONANCE IMAGING has long been rec-
ognized as a useful tool for the non-invasive evaluation
of the thoracic vasculature. Unlike computed tomogra-
phy and conventional angiography, MRI is not associ-
ated with the concerns related to ionizing radiation
exposure or to contrast-related nephrotoxicity. MRI is
also capable of oblique image acquisition and multipla-
nar reformation, which aids the illustration of the
thoracic vessels, inherently intertwined and complex in
their arrangements. In addition, MRI using cine tech-
nique affords cardiac referenced data that enables dy-
namic assessment of blood flow, yielding information
comparable to an echocardiogram.
Gadolinium (Gd)-enhanced three-dimensional (3D)
magnetic resonance angiography (MRA) is a newer
technique that provides high-resolution (ie, 3D) data
very quickly and is well suited for the depiction of
intrathoracic vessels. Improvements in gradient technol-
ogy now allow a Gd-enhanced 3D MRA to be performed
during a 20–40 second breath-hold. Because it relies on
T1-shortening effects of circulating Gd-chelate contrast
media and not inherent flow characteristics, Gd-
enhanced 3D MRA can often depict pathologic vascular
segments that are not adequately visualized using unen-
hanced flow-based MRI techniques. In addition, Gd-
enhanced 3D MRA provides volumetric data that can be
processed for multiplanar reformation (MPR) and maxi-
mum intensity projection (MIP) viewing. In this article,
the technical considerations and potential applications
for Gd-enhanced 3D MRA of the systemic and pulmo-
nary vessels within the chest will be discussed and
illustrated.
Traditionally, T1-weighted spin-echo and gradient-
echo pulse sequences have been employed for delinea-
tion of vascular pathology within the chest (1–10). The
combination of T1-weighted spin-echo and gradient-
echo images can often provide the information neces-
sary for the assessment of simple clinical queries such
as patency of a vessel (Fig. 1) or delineation of a vascular
ring (Fig. 2). These techniques, however, rely on flowing
blood (ie, the movement of blood during the acquisition
period) for their illustration of vascular structures. This
flow dependency makes these techniques prone to flow-
related image artifacts, thereby frequently limiting their
clinical utility.
On spin-echo pulse sequences, vessels are character-
ized by their dark lumina. The black appearance of
blood, also known as flow void, on spin-echo imaging
occurs secondary to the wash-out of blood prior to the
refocusing pulse and sampling of the echo. The wash-
out may be incomplete if the echo time is too short, the
vessel courses primarily within the imaging plane, or
the blood flow is too slow. Incomplete wash-out results
in the persistence of signal within the vessel lumen,
which may result in the masking of underlying luminal
pathology such as an intimal tear or the erroneous
simulation of a vascular occlusion or thrombosis. A
superior black blood effect is achieved by using prepara-
tory pulses such as a double inversion pulse to null
blood signal for more effective suppression even when
the blood flow is slow.
Unlike spin-echo imaging, time-of-flight (TOF) and
phase contrast (PC)-MRA depict flowing blood with
bright signal intensity. TOF imaging relies on the wash-in
or in-flow effect of unsaturated protons; PC imaging
relies, on the phase shift experienced by moving protons
traveling along the gradient field (7–13). Both TOF and
PC imaging provide higher intra-vascular signal-to-
noise ratios than spin-echo pulse sequences. These
‘‘bright blood’’ pulse sequences (ie, TOF and PC imaging)
often show intraluminal abnormalities (Fig. 1b) not
clearly identified on black blood spin-echo images.
However, should blood flow be slow, turbulent, or com-
plex, vascular signal on gradient-echo images becomes
unreliable. Disturbances in blood flow can often result
in signal loss, which can result in the underestimation
of vessel patency, overestimation of a stenosis, or even
simulation of a vascular occlusion.
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Gd-enhanced 3D MRA is a relatively new technique
that has the advantages of higher resolution, shorter
acquisition time, speed, and improved reliability for the
generation of vascular signal than the aforementioned
flow-dependent MRI techniques (ie, spin-echo and gra-
dient-echo imaging) (3,4,6,8,9,14). Gd-enhanced 3D
MRA often compliments traditional spin-echo and gradi-
ent-echo imaging for comprehensive evaluation of intra-
thoracic vascular structures.
Gd-ENHANCED 3D MRA
Physical Principles of Gd-Enhanced 3D MRA
Vascular visualization using Gd-enhanced 3D MRA
relies on the T1 shortening of blood by Gd-chelate
contrast media during its intravascular transit (13–17).
This technique requires the coordination of an intrave-
nously administered Gd-chelate contrast media bolus
with image acquisition. The timing of the imaging deter-
mines the vascular territory ultimately illustrated. That
is, if the imaging is performed during the arterial phase
of the contrast bolus, arteries will be preferentially
illustrated. Because Gd-enhanced 3D MRA relies on T1
shortening effect of contrast media rather than on blood
flow characteristics such as wash-out, TOF, or PC
effects, it is less prone to flow-related artifacts and is
capable of more reliably illustrating vascular struc-
tures.
Different regions of k-space have varying importance
for Gd-enhanced 3D MRA. Image contrast depends
mainly on central k-space data. For most pulse se-
quences sequential ordering of k-space is employed
such that the center of k-space is acquired during the
middle or center of the imaging period. Since central
k-space determines image contrast, only vessels that
are contrast media-enhanced during the acquisition of
central k-space will be visualized on Gd-enhanced 3D
MRA. Preferential arterial images can be achieved, there-
fore, by selectively timing the acquisition of central
k-space views during preferential arterial enhancement
Figure 1. Axial spin echo (a) and axial 2D TOF (b) of the chest at the level of the arch showing large mediastinal mass encasing the
SVC, trachea, and upper lobe branch of the pulmonary vessels. Both SE and 2D TOF depict intra- and extravascular anatomy.
Figure 2. Double aortic arch. Axial T1 SE (a) and axial 2D TOF (b).
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Figure 3. MIP reformats from coronal 3D Gd-MRA of normal aortic arch and the great vessels in coronal plane. Coronal
reformation in (a) arterial phase and (b) equilibrium phase. Sagittal reformation in (c) arterial phase and (d) equilibrium phase.
Subtle susceptibility artifact (arrow) from concentrated gadolinium during the arterial phase mimics stenosis at proximal
innominate artery (c), and the venous phase confirms normal, patent innominate artery (d).
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(Fig. 3a,c). Venous structures will be seen if central
k-space lines are obtained during the venous or equilib-
rium phase of the contrast bolus (Fig. 3b,d). The timing
of the central k-space views relative to the contrast
administration, therefore, is crucial for the resultant
vascular visualization. The periphery of k-space that
contributes primarily to image resolution is also impor-
tant. However, its acquisition is less time sensitive.
Imaging Parameters
For thoracic imaging, 3D Gd-enhanced MRA is per-
formed in a breath-hold to minimize the artifacts (ie,
image blurring) related to respiratory motion. For this
reason, the fastest possible 3D imaging sequence, typi-
cally a fast 3D gradient-echo pulse (16–23), should be
used. The partition dimensions (ie, partition thickness,
matrix size, field of view) should be prescribed to achieve
the smallest possible voxel size (eg, 2 mm or less in any
single dimension) to afford sufficient spatial coverage of
the target vessel and yet still be acquired within a
breath-hold. For the thoracic aorta, the typical 3D
volume employs a 2–3 mm partition thickness, 256 3
192 matrix, and 30 cm field of view. On most current
commercially available 1.5 T MR scanners, a fast 3D
gradient-echo pulse sequence using the shortest pos-
sible repetition time (eg, 4–6 msec), shortest possible
echo time (eg, 1–3 msec), and a 30–40° flip angle can be
performed within 20–40 seconds. The imaging time can
be decreased by using partial Fourier imaging (eg, 0.5
excitation), decreased number of partitions, decreased
phase encoding steps, or a rectangular field of view.
Widening bandwidth also makes the scan faster but at
the expense of a significant reduction in signal-to-noise
ratio. These improvements in imaging speed can be
used to improve image resolution (ie, decrease voxel
size). Recently, image interpolation using zero-filling
has gained popularity as it improves the MIP images at
no additional cost to imaging time (24), although image
reconstruction and post-processing time increases. It is
important to note that although zero-filling generates
better reformations and MIPs, it does not improve the
true spatial resolution of the images.
Thoracic Gd-enhanced 3D MRA should be prescribed
for a sagittal, coronal, or oblique sagittal acquisition
(Fig. 4). The images should be obtained in the orienta-
tion optimal for visualization of the target structure. For
illustration of the pulmonary arteries and veins, for
example, Gd-enhanced 3D MRA should be performed in
Figure 4. Illustration of coronal locator and sagittal locator demonstrating the positioning of the Volume and Tracker for coronal
3D Gd-MRA.
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the coronal plane for both lungs (Fig. 5) or sagitally for
just one lung. Coronal acquisitions afford diagnostic
views of the thoracic aorta and are preferable should
evaluation of the subclavian arteries be desired. How-
ever, sagittal or oblique sagittal [left-anterior-oblique
(LAO) view] prescriptions are recommended if higher
resolution images are desired of the aortic arch as this
will optimize anatomic coverage using the highest pos-
sible spatial resolution (ie, smallest voxel size). Sagittal
acquisitions also have the advantage of facilitating the
use of fractional or rectangular fields of view (ie, phase
direction anterior to posterior) with minimal concerns
from aliasing of the image data. A rectangular field of
view shortens the overall scan time, thereby reducing
the breath-holding time.
Timing of Image Acquisition
As mentioned, proper coordination of the central k-space
views with peak enhancement of the target vessels is
essential for Gd-enhanced 3D MRA. Imaging prema-
turely can result in incomplete vascular depiction.
Imaging too late may result in insufficient signal within
the target vessel.
Timing is more important for arterial imaging than
venous imaging, as the arterial first pass of the bolus
may be brief. Arterial phase Gd-enhanced 3D MRA can
be timed several ways. The easiest method is using a
fixed scan delay (ie, ‘‘best guess’’ or ‘‘educated guess’’)
(3,8,16). For a typical 30–40 second sequentially or-
dered fast 3D gradient-echo pulse sequence with a 0.2
mmol/kg contrast bolus (ie, 30–40 mL) injected at 2
mL/sec, the imaging of the thoracic aorta should begin
approximately 10 seconds after the beginning of the
intravenous infusion. For the pulmonary arteries, imag-
ing should begin within 2–3 seconds after the contrast
media injection has begun. Because timing mismatch is
more often encountered with fixed time delay acquisi-
tions, longer and larger contrast media infusions (ie, 0.2
mmol/kg dose of contrast media) are recommended for
this method.
A more ‘‘precise’’ method for estimating the arrival
time of contrast media into the target vasculature is the
performance of bolus timing scan using a 1–2 mL test
bolus of contrast media (16,19,25,26). Imaging is typi-
cally performed using a fast 2D gradient-echo pulse
sequence over the target structures with a temporal
resolution of approximately one image every 1–2 sec-
onds. A large flip angle and either a preparatory pulse or
image in the plane of the aorta are used to eliminate
bright in-flow signal from the TOF effect. This prelimi-
nary scan will yield the time required for peak enhance-
ment of the target vasculature. Using this information,
the appropriate time delay to align the central k-space
lines with arterial enhancement can be calculated (8).
The third method for timing Gd-enhanced 3D MRA
relies on the triggering of the image acquisition in real
time. One such method (MR SmartPrep, General Elec-
tric Medical Systems, Milwaukee, WI) (27–29) monitors
signal intensity within an operator-defined monitoring
volume encompassing part of the target vasculature (eg,
descending aorta for imaging the thoracic aorta) to
determine when to initiate data acquisition. The moni-
toring volume can be placed in a cardiac chamber
should pulmonary imaging be desired (29). The bolus
detection algorithm has the advantage of automation. It
also can be performed successfully with hand infu-
sions. A similar approach using visual cues with MR
fluoroscopy (30) has also been successfully imple-
mented.
Fixed delay times are typically successful for Gd-
enhanced 3D MRA of the thoracic arteries. Timing the
acquisition with a test bolus or real-time triggering
method, however, can diminish the dose of contrast
media (eg, to as low as 20 mL) required for achieving
diagnostic images. Irrespective of timing choice, two
post-contrast 3D MRA acquisitions should be per-
formed. The initial 3D MRA is typically performed
during a breath-hold for the arterial phase images and
the second 3D MRA immediately after the first (ie,
second breath-hold) for the venous or more appropri-
ately termed equilibrium phase imaging. The use of this
dual-phase imaging in the thorax will assist segmenta-
tion of the arterial and venous structures. Even if
pulmonary venous imaging is desired, the performance
of coronal dual-phase images of the pulmonary circula-
tion is recommended. The early arterial phase images
(ie, images of the pulmonary arteries) can assist in the
identification of arterial and venous segments, which
are typically similarly bright on equilibrium phase im-
ages. The same dual-phase regimen is recommended for
arterial imaging. Equilibrium phase images often com-
pliment arterial phase images, which may insufficiently
illustrate arterial structures because of arterial artifacts
that occur on the initial arterial phase (Figs. 3, 6) or slow
arterial flow (Fig. 7c,d). Dual-phase imaging often com-
pensates for failures of timing and is a quick and
inexpensive option.
To improve timing further, several investigators have
proposed alternative methods of k-space phase order-
ing. One strategy is to acquire the central lines of
Figure 5. MIP from 3D Gd-MRA demonstrating large anoma-
lous pulmonary vein (arrows) draining into the right atrium.
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k-space early during the imaging period (27,30). This
technique, called centric phase ordering, has theoreti-
cal advantages over traditional sequential phase order-
ing where the center k-space views are acquired in the
middle of the imaging period. Centric phase ordering
enables the acquisition of the crucial image contrast
data first. This can improve the ability to ‘‘catch’’ the
arterial phase of arteries during brief periods of prefer-
ential enhancement (eg, carotid arteries) especially when
implemented as elliptical centric (19,20). This also may
be beneficial for imaging patients with limited breath-
holding ability, ensuring that the critical central k-space
data is acquired earlier during the breath-hold (21,22).
Incomplete breath-holding would thus only corrupt
peripheral lines of k-space and result in less significant
degradation of image contrast.
Centric phase ordering of the 3D MRA, however, has
disadvantages related to its sensitivity to fluctuations in
signal intensity as seen during the arrival of Gd-chelate
contrast media. Premature acquisition of images using
a centric phase ordered Gd-enhanced 3D MRA can have
significant ringing artifact. This artifact is recognized by
alternating bright and dark bands, which parallel vascu-
lar structures and can render the study non-diagnostic.
Alternative k-space methods such as elliptical centric
phase ordering have been suggested to reduce these
‘‘ringing’’ artifact (21).
Contrast Bolus
Gd-chelate contrast media is typically administered
intravenously via hand bolus or MR-compatible injec-
tor. In either case, the injection should be followed by a
saline flush (typically 15–20 mL) to ensure that the
entire contrast media bolus has been administered. The
right arm is the preferred intravenous site because it
has a more direct path to the heart compared to the left
arm (31). Kopka et al (32) have shown that an injection
rate of 2 mL/sec is ideal for Gd-enhanced 3D MRA. A
minimum dose of at least 0.12 mmol/kg (8) (roughly 20
mL of Gd-chelate contrast media) is required for imag-
ing the thoracic aorta, great vessels and pulmonary
vasculature. Better quality is possible with higher doses,
and we routinely use 40 mL for thoracic MRA.
Particular attention should be taken when evaluating
the great vessels on Gd-enhanced 3D MRA. The arrival
of contrast media in the subclavian and bracheoce-
hpahlic veins is typically very concentrated and can
transiently decrease T2*. This susceptibility or T2*
artifact can dephase signal within the veins and adja-
cent structures (Figs. 3c, 6b). The arm contralateral to
the suspected abnormal vessel should therefore be
injected in order to minimize this artifact in the region of
interest. In addition, use of a short echo time will also
reduce the artifact. This artifactual signal drop-out is
seen only during the arterial phase of the 3D Gd-MRA
when the concentration of Gd is greatest. Inspection of
the equilibrium phase images will help avoid erroneous
diagnoses resulting from this artifact (Fig. 3d). When it
is important to see subclavian arteries, it may be useful
to use a fast injection of a lower dose (20 ml) followed
immediately by a fast saline flush (50 ml at 5 ml/sec) to
clear gadolinium from the subclavian vein before central
k-space data are acquired. If venous visualization is the
target of the study, a high dose of contrast media (eg, 40
mL) should be administered for Gd-enhanced 3D MRA
Figure 6. MIP reformats from coronal 3D Gd-MRA demonstrate severe stenosis of proximal left subclavian artery (arrow). a:
Oblique sagittal plane. b: Coronal plane. Signal drop-off from concentrated gadolinium at mid-subclavian artery mimics stenosis
(asterisk).
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to ensure sufficiently high venous concentrations of Gd
during the equilibrium phase imaging.
An alternative method for central venous imaging is to
administer a diluted dose of Gd-chelate contrast media
directly into the vein of interest. For this alternate
venographic technique, 10–20 mL of Gd-chelate con-
trast media is mixed into a 250 mL bag of normal saline.
A 120 mL bolus (requires two 60 ml syringes) of the
diluted Gd-chelate contrast media should be adminis-
tered intravenously into an antecubital vein of the
symptomatic extremity at a rate of at least 2 mL/sec.
Imaging should start within 5–10 seconds after the
initiation of the contrast injection, with the patient
suspending breathing in full inspiration. For bilateral
upper extremity illustration, two 120 mL injections of
the diluted contrast media (ie, total of 240 mL) should be
injected simultaneously (120 mL into each arm).
Gd-Enhanced 3D MRA Image Processing
Gd-enhanced 3D MRA provides high-resolution images
of the vessels as ‘‘luminograms’’ and can be displayed as
maximum intensity projections (MIP), which are views
similar to those of conventional angiography—views
familiar to clinicians. A major advantage of Gd-en-
hanced 3D MRA over conventional angiography, which
is limited to planar 2D image display, is the ability of
Gd-enhanced 3D MRA data to be reformatted into
planes different from the original acquisition. MPR and
subvolume MIPs are a particularly helpful tool for the
evaluation of the thoracic vessels, which are often
overlapping.
Patient Preparation
Preparing the patient for a Gd-enhanced 3D MRA exami-
nation is an important step. As always, the patient’s
fears should be allayed prior to imaging, and communi-
cation with the patient to include an explanation of the
procedure (especially of the breath-holding) should be
initiated prior to scanning. A preliminary breath-hold
prior to imaging can serve as a guide to the patient’s
breath-hold capacity. Using supplemental oxygen and
hyperventilation, most patients, even those with respira-
tory disease, can hold their breath for 20–30 seconds
(34). Reasonably healthy individuals can suspend
breathing 40–50 seconds without difficulty when lying
down relaxed inside the magnet.
The placement of a 20 gauge intravenous angiocath-
eter prior to entering the scan room will minimize the
scanner time requirements. Similarly, the setup of the
intravenous tubing set and drawing of the saline flush
and contrast media in advance will also diminish the
demands on scanner time. It is helpful to use a standard-
Figure 7. Aortic dissection type III (Stanford B). The intimal flap demonstrated as linear intermediate signal in the sagittal
spin-echo sequence (a), and as low signal in axial 2D TOF (b). The slow flow in the false lumen has lower signal than the normal
flow in the true lumen (b). Early filling of the true lumen in arterial phase (c). Compared with delayed filling of the false lumen in
the equilibrium phase (d).
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ized tubing setup so the operator will know the tubing
dead space and the flow resistance to contrast injection.
The patient is typically positioned feet first with head
toward the operator. This allows more direct communi-
cation between the operator and the patient. Positioning
of the patient feet first also facilitates the operator’s
visualization of the patient’s anterior chest wall and
respiratory excursion to verify that the patient is follow-
ing breathing instructions. Placement of a respiratory
bellows around the patient’s chest can be helpful for
monitoring the patient’s respiratory cycle and estimat-
ing potential breath-hold capacity. However, the delay
in scanner display of the respiratory bellows data is
typically several seconds, and direct observation of the
patient’s breathing is often a more accurate method for
the initiation of breath-hold scanning.
Imaging can be improved by the use of a torso phased-
array coil. However, the phased-array coil will restrict
the cranial-to-caudal extent of the imaging field of view.
Larger fields of view may be necessary for imaging a
patient with a thororacoabdominal aortic aneurysm or a
thoracic aortic dissection, which extends into the ab-
dominal aorta. Use of the phased-array coils often adds
to setup time, as additional care must be taken to
ensure that it is properly centered prior to the Gd-
enhanced 3D MRA. Another consideration of phased-
array coils is the time required for the processing of the
image data, which can be significant if the scanner does
not have sufficiently fast array processors or memory.
In most cases, the body coil is adequate for thoracic
Gd-enhanced 3D MRA and is the simplest coil choice.
THORACIC APPLICATIONS OF Gd-ENHANCED
3D MRA
Gd-enhanced 3D MRA is a versatile technique for imag-
ing thoracic arteries and veins. In the sections to follow,
potential applications for Gd-enhanced 3D MRA of the
systemic circulation (thoracic aorta and central veins)
and pulmonary circulation (pulmonary arteries and
pulmonary veins) will be briefly discussed and illus-
trated. In addition, MRA for the delineation of aberrant




One of the most common vascular indications for tho-
racic MRI is the evaluation of known or suspected aortic
pathology. Although a variety of entities can affect the
aorta, imaging should not only identify the lesions but
Figure 8. Aneurysm of the ascending aorta in Marfan’ syndrome. a: Axial T1 SE. b: Axial 2D TOF. c: Sagittal MIP projection. The
arrow points to the site of anastomosis between the native aneurysmal aorta and the graft placed in prior surgery to correct the
aortic root aneurysm (c). Note associated chest wall deformity (a, b).
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also accurately characterize their location, extent, and
involvement of branch vessels. In addition, the examina-
tion must be able to assess the salient features required
for surgical planning.
MRI of an aortic aneurysm (Fig. 8) should demon-
strate the site of aneurysm, its length, morphology (ie,
fusiform versus saccular), and relationship to aortic
branches. From these features, the etiology can often be
determined. Atherosclerotic aneurysms, for example,
can occur anywhere, but typically involve the descend-
ing aorta and are fusiform. Mycotic aneurysms (Fig. 9)
are commonly saccular and involve the ascending aorta,
arch or the aorta near the diaphragm. In addition,
images should illustrate the relationship of the aneu-
rysm to the branch vessels and the presence of mural
thrombus or a penetrating ulcer, all of which can affect
surgical decision making. T1-weighted spin-echo and
gradient-echo images can often be sufficient for the
simple identification of a suspected aneurysm (ie, is
there an aortic aneurysm?) or follow-up assessment of
known aneurysms to monitor its size. However, Gd-
enhanced 3D MRA provides more comprehensive infor-
mation more reliably and faster than these other meth-
ods without even requiring electrocardiographic gating.
Similar observations can be made for MRI of aortic
dissections. In fact, the location and relationship of the
intimal tear is critical to the choice of management.
Aortic dissections involving the ascending aorta (Stan-
ford A, Fig. 10a) are associated with higher mortality
and mandate surgical repair. Stanford A dissections
have increased risk for myocardial infarct secondary to
extension of the dissection into the coronary arteries, of
pericardial temponade secondary to aortic rupture into
the pericardium, and possibly of stroke secondary to
involvement of the carotid or vertebral arteries. Dissec-
tions arising distal to the left subclavian (Stanford B,
Figs. 7, 10b) are less precarious and are usually man-
aged medically. MRA must evaluate the extent of dissec-
tion, entry and reentry sites, true and false channel size
and patency, and branch vessel involvement. Because
of the possibilities for an aortic dissection without
intimal flap (intramural hematoma) where a discrete
intimal tear is not evident, pre-contrast T1-weighted
spin-echo imaging is necessary. On T1-weighted spin-
echo images, the intramural hematoma is identified as
concentric thickening of the aortic wall with increased
intramural signal intensity, which is related to methemo-
globin within the hematoma (35).
Stenosis or occlusion of the great vessels may be
caused by atherosclerosis, dissection, and arteritis
(Takayasu’s arteritis, giant cell arteritis). Other rare
causes include fibromuscular dysplasia, post-radiation
arteritis, and mediastinal inflammatory or neoplastic
disease. The patient commonly presents with upper
extremity ischemia and/or neurologic symptoms from
the steal phenomena during arm exercise. Coronal 3D
Figure 9. MIP reformats from coronal 3D Gd-MRA demonstrate a mycotic pseudoaneurysm at the site of coarctation, ruptured
as a complication from bacterial endocarditis in (a) sagittal and (b) axial planes. Pseudoaneurysm lumen (asterisk), true lumen
(arrowhead), and the neck (arrow).
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Figure 10. MIP reformats from coronal 3D Gd-MRA show aortic dissections with intimal flap. a: DeBakey type 1 (Stanford type A)
dissection. b: DeBakey type 3 (Stanford type B) dissection. Note susceptibility artifact from the metallic stent (arrow).
Figure 11. Sagittal spin echo (a) and 3D Gd-MRA reformats (b) of the thoracic aorta demonstrate aortic coarctation (arrows)
distal to the left subclavian artery origin. Note the large collateral bypassing the coarctation.
Gd-MRA is the best sequence to assess origins of the
innominant artery, common carotids, vertebral, and
subclavian arteries (Fig. 6). The shortest possible echo
time should be used to minimize the susceptibility
artifact from the lung and from the concentrated gado-
linium in the subclavian and/or innominate veins.
Inject the gadolinium via the arm contralateral to the
suspected abnormal vessel to avoid artifact from highly
concentrated gadolinium in the veins which can mimic
stenosis in the subclavian and/or innominate arteries.
Less commonly, patients with suspected congenital
lesions such as vascular rings or aortic coarctation are
referred for MRI. Standard T1-weighted spin-echo and
gradient-echo images frequently are sufficient for con-
firming a vascular ring (Fig. 2) or aortic narrowing. In
the case of aortic coarctation, Gd-enhanced 3D MRA
can provide important complimentary information (Fig.
11). Signal drop in the aorta distal to the coarctation
may be seen on cine MRA (gradient echo) indicating that
the stenosis is significant. This signal drop is caused by
flow turbulence distal to the stenosis, resulting in spin
dephasing. The degree of dephasing provides a rough
qualitative assessment of the severity of stenosis and
helps in differentiating a pseudocoarctation (Fig. 12)
from a true coarctation of the aorta. Quantitative mea-
surements can be obtained by using velocity-encoded
cine MRA, which allows pressure gradient measures
across the coarctation. In addition, velocity-encoded
cine MRA can demonstrate the reversed flow pattern in
the descending aorta distal to the coarctation, due to
collateral flow (28).
Other congenital anomalies of the aorta including
aortopulmonary window, aberrant subclavian arteries,
patent ductus arteriosus, and interrupted arch are also
well identified on MRA (2,29).
Bracheocephalic Veins and Superior Vena Cava
MRI of the central veins is typically performed for the
assessment of venous patency, for which traditional
spin-echo and gradient-echo (especially TOF technique)
images are often sufficient (Fig. 1) (36). Venous imaging
can be achieved during the equilibrium phase of a
coronal Gd-enhanced 3D MRA using a higher dose of
contrast media or during the initial (arterial) phase of a
coronal Gd-enhanced 3D MRA using a injection of
diluted contrast media bolus into the ipsilateral arm.
Pulmonary Circulation
Pulmonary Arteries
A common clinical indication for pulmonary artery
imaging is the evaluation of patients suspected of hav-
ing a pulmonary embolism. The use of traditional MRI
pulse sequences for imaging the pulmonary vessels
presents a great challenge due to the large local dephas-
ing resulting from multiple air-soft tissue interfaces, as
well as artifacts related to cardiac and respiratory
motion (23,37). The main pulmonary artery and the
right and left pulmonary arteries can usually be seen on
T1-weighted spin-echo sequences with the assistance of
respiratory and cardiac gating. Thrombus appears as
intermediate signal within the signal void pulmonary
artery. However, the varying flow direction within these
vessels as well as the potentially diminished flow may
lead to incomplete wash-out and to the erroneous
simulation of a thrombus.
More recently, Gd-enhanced 3D MRA has been dem-
onstrated for imaging patients with suspected pulmo-
nary embolism (Fig. 13). Gd-enhanced 3D MRA is espe-
cially helpful for imaging patients with indeterminate
pulmonary ventilation and perfusion (ie, V/Q) scinti-
graphic studies and contraindications to the use of
iodinated contrast agents. Several studies have re-
ported high sensitivity and specificity for Gd-enhanced
3D MRA in detecting pulmonary embolism up to the
subsegmental branches (22,23,38,39).
Pulmonary Veins
MRI of the pulmonary veins is a fairly infrequent request
but has been shown to be helpful for the evaluation of
anomalous pulmonary venous return in patients with
suspected congenital heart disease (30). The pulmonary
veins, which carry oxygenated blood, normally drain
into the left atrium, where blood is pumped into the left
ventricle and the systemic arterial circulation. The
pre-operative determination of pulmonary venous drain-
age is important for certain surgical repairs such as
atrial septal defects, which have a higher association
with anomalous pulmonary venous drainage. Standard
T1-weighted spin-echo and gradient-echo images often
Figure 12. Pseudocoarctation of the thoracic aorta (arrow) on
sagittal oblique subvolume MIP. Note the high aortic arch and
unusually large A-P window typical of pseudocoarctation in
which the aorta becomes ectatic and elongated with kinks that
resemble coarctation but are not hemodynamically significant.
Also note that no collaterals are present.
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have insufficient contrast-to-noise ratio and spatial
resolution to differentiate the individual lobar pulmo-
nary veins accurately from their accompanying arteries.
This is especially true in children, for whom most of
these studies are requested. Gd-enhanced 3D MRA can
provide excellent depiction of the pulmonary veins (Fig.
5) and compares favorably with and is arguably better
than images obtained during the venous phase (ie,
Figure 13. MIP reformats from coronal 3D Gd-MRA show a non-occlusive thrombus (arrow) of the left main stem pulmonary
artery in (a) sagittal and (b) coronal planes.
Figure 14. Patent ductus arteriosus in (a) axial spin echo and (b–d) MIP from coronal 3D Gd-MRA demonstrates the
communication between the aorta and main pulmonary artery (arrow).
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levo-phase) of a conventional pulmonary angiogram
(41).
Systemic-Pulmonary Circulation Connections
With the advantages of high-resolution 3D data and
MPR, Gd-enhanced 3D MRA can often define small-
caliber vessels or vascular channels not well visualized
on T1-weighted or gradient-echo images. It is not sur-
prising, therefore, that this technique can be particu-
larly helpful for the identification of systemic-pulmo-
nary circulation connections (ie, shunt lesions), which
may often be subtle. Intracardiac shunts (eg, atrial
septal defects and ventricular septal defects) are usu-
ally well delineated using T1-weighted spin-echo and
gradient-echo images. However, these flow-based se-
quences often fail to delineate extracardiac shunts
adequately because they supply insufficient contrast-to-
noise ratio or the flow within the shunts is too complex
for them to generate sufficient signal. Gd-enhanced 3D
MRA can often better define these anomalous connec-
tions (Fig. 14) because they generally will fill with
contrast media. MPR untangles overlapping structures
for better visualization of the anomalous connection.
Gd-enhanced 3D MRA also has the advantages of MIP
display for presentation of views familiar to the surgeon.
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